That is correct, but you reminded me of something quite fascinating that I did officially predict about the great Dr. Liau…
Dr. Steinman was award the Nobel Prize for discovering the dendritic cell. In 2018, James P. Allison and Tasuku Honjo were awarded the Nobel Prize in Physiology or Medicine for their pioneering work in cancer therapy through the discovery of immune checkpoint inhibitors.
Today, Dr. Linda Liau and Dr. Pawel Kalinski are combining dendritic cell technology with checkpoint blockade technology to reach new levels of efficacy and healing for patients! UCLA and Roswell are studying how these two Nobel Prize-winning discoveries can be combined to treat multiple distinct cancers!
These combo trials are relatively new and have only recently reached PII clinical investigation.
If the researchers who discovered these two technologies were awarded the Nobel Prize, why wouldn’t the researchers who discovered the combo be considered for the Nobel Prize?
Recently, we commemorated the loss of the great Dr. Ralph Steinman 13 years ago on September 30th.
“We know he will live on through his scientific contributions.”
Dr. Steinman’s legacy is changing the field of cancer immunotherapy today, and his invaluable Nobel Prize-winning work lives on at UCLA, King’s College and Roswell Park, among other cutting-edge institutions.
The recent evolution of dendritic cell technology has been vast, and Dr. Steinman’s prophetic words foreshadowed the future and DCVax-L. In the last 3 minutes of the YouTube video, Dr. Steinman describes the “first generation of this approach” which used only ONE single antigen. Consider that DCVax-L can present HUNDREDS of distinct antigens today!
Market Data 
Markets 
AI
